Pub Date : 2026-03-18DOI: 10.1136/jech-2025-224945
Linyang Song, Zhujun Zhong, Jing Qi, Yang Wan, Peiyuan Qiu
Background: Frailty is dynamic. However, the relationship between handgrip strength (HGS) weakness, asymmetry and frailty progression is still unclear.
Methods: This cohort study used data from waves 4-9 (2008-2009 to 2018-2019) of the English Longitudinal Study of Ageing (ELSA) and waves 10-15 (2010 to 2020) of the Health and Retirement Study (HRS). HGS weakness was assessed by maximal HGS, and asymmetry by the ratio of HGS in the nondominant hand to that in the dominant hand. Frailty was assessed by frailty index (FI). Linear mixed-effect models were employed for our analyses. Random-effects meta-analyses were conducted to pool the results from the ELSA and HRS studies.
Results: A total of 7598 participants from ELSA and 7304 from HRS were included. After full adjustment, weakness (pooled β=0.796; 95% CI 0.504 to 1.089; p<0.001) and asymmetry (pooled β=0.072; 95% CI 0.017 to 0.126; p=0.010) were independently associated with accelerated frailty progression. For the combined status of these two indicators, individuals with both weakness and asymmetry exhibited the highest baseline FI (pooled β=12.772; 95% CI 11.756 to 13.789; p<0.001) and the fastest FI progression (pooled β=0.976; 95% CI 0.826 to 1.127; p<0.001). Moreover, HGS status changed over time, with distinct transition patterns being associated with different rates of frailty progression.
Conclusions: Incorporating HGS testing into annual health check-ups can aid in the early identification of HGS weakness and asymmetry, which may help prevent frailty progression.
{"title":"Exploring independent and joint effects of handgrip strength weakness and asymmetry on frailty progression: findings from two longitudinal cohorts.","authors":"Linyang Song, Zhujun Zhong, Jing Qi, Yang Wan, Peiyuan Qiu","doi":"10.1136/jech-2025-224945","DOIUrl":"https://doi.org/10.1136/jech-2025-224945","url":null,"abstract":"<p><strong>Background: </strong>Frailty is dynamic. However, the relationship between handgrip strength (HGS) weakness, asymmetry and frailty progression is still unclear.</p><p><strong>Methods: </strong>This cohort study used data from waves 4-9 (2008-2009 to 2018-2019) of the English Longitudinal Study of Ageing (ELSA) and waves 10-15 (2010 to 2020) of the Health and Retirement Study (HRS). HGS weakness was assessed by maximal HGS, and asymmetry by the ratio of HGS in the nondominant hand to that in the dominant hand. Frailty was assessed by frailty index (FI). Linear mixed-effect models were employed for our analyses. Random-effects meta-analyses were conducted to pool the results from the ELSA and HRS studies.</p><p><strong>Results: </strong>A total of 7598 participants from ELSA and 7304 from HRS were included. After full adjustment, weakness (pooled β=0.796; 95% CI 0.504 to 1.089; p<0.001) and asymmetry (pooled β=0.072; 95% CI 0.017 to 0.126; p=0.010) were independently associated with accelerated frailty progression. For the combined status of these two indicators, individuals with both weakness and asymmetry exhibited the highest baseline FI (pooled β=12.772; 95% CI 11.756 to 13.789; p<0.001) and the fastest FI progression (pooled β=0.976; 95% CI 0.826 to 1.127; p<0.001). Moreover, HGS status changed over time, with distinct transition patterns being associated with different rates of frailty progression.</p><p><strong>Conclusions: </strong>Incorporating HGS testing into annual health check-ups can aid in the early identification of HGS weakness and asymmetry, which may help prevent frailty progression.</p>","PeriodicalId":54839,"journal":{"name":"Journal of Epidemiology and Community Health","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147482276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-18DOI: 10.1136/jech-2025-224810
Irene Martínez-García, Alicia Saz-Lara, Carlos Pascual-Morena, Carla Geovanna Lever-Megina, Silvana Patiño-Cardona, Fernando Ribeiro, Iván Cavero-Redondo
Introduction: Accumulation of advanced glycation end products, measured by skin autofluorescence (SAF), has been shown to be associated with several chronic non-communicable diseases, particularly cardiovascular diseases (CVDs). The promotion of physical activity (PA) as a strategy for the prevention of CVD by modifying healthy habits has been widely studied.
Aim: To assess the evidence for the association between PA and SAF in the general adult population.
Methods: A systematic review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and the Synthesis Without Meta-analysis framework. A search was performed in MEDLINE (via PubMed), Web of Science, Scopus, Cochrane Library and SportDiscuss (via EBSCOhost), from inception to September 2024. Study quality was assessed using the National Heart, Lung and Blood Institute tools and the certainty of evidence was evaluated with Grading of Recommendations, Assessment Development and Evaluation. Vote counting based on the direction of effect was used as the standardised synthesis metric.
Results: In the systematic review, 17 studies were included. The qualitative synthesis showed a predominant consistency in favour of a beneficial association. Specifically, 58.8% of the studies reported a statistically significant inverse association, indicating that higher levels of PA or exercise frequency are correlated with lower SAF levels. The remaining studies (41.2%) reported non-significant results, though several showed favourable trends. No studies reported a positive association between PA and SAF. The quality of the studies was generally fair, and the certainty of evidence low.
Conclusions: PA is inversely associated with SAF. Therefore, while causality cannot be proven, it is hypothesised that PA may reduce SAF and thus have a positive impact on health.
通过皮肤自身荧光(SAF)测量的晚期糖基化终产物的积累已被证明与几种慢性非传染性疾病,特别是心血管疾病(cvd)有关。促进身体活动(PA)作为一种通过改变健康习惯来预防心血管疾病的策略已被广泛研究。目的:评估普通成人PA和SAF之间关系的证据。方法:根据系统评价和荟萃分析指南的首选报告项目和无荟萃分析的综合框架进行系统评价。在MEDLINE(通过PubMed)、Web of Science、Scopus、Cochrane Library和SportDiscuss(通过EBSCOhost)中进行了检索,检索时间从成立到2024年9月。使用国家心脏、肺和血液研究所的工具评估研究质量,并通过推荐分级、评估发展和评估来评估证据的确定性。采用基于效应方向的计票作为标准化综合指标。结果:系统评价纳入17项研究。定性综合显示了有利关联的主要一致性。具体而言,58.8%的研究报告了统计学上显著的负相关,表明较高水平的PA或运动频率与较低的SAF水平相关。其余的研究(41.2%)报告了不显著的结果,尽管一些研究显示了有利的趋势。没有研究报道PA和SAF之间的正相关。研究的质量总体上是公平的,证据的确定性较低。结论:PA与SAF呈负相关。因此,虽然因果关系无法证明,但假设PA可能会减少SAF,从而对健康产生积极影响。
{"title":"Analysis of the potential association between physical activity and skin autofluorescence: a systematic review.","authors":"Irene Martínez-García, Alicia Saz-Lara, Carlos Pascual-Morena, Carla Geovanna Lever-Megina, Silvana Patiño-Cardona, Fernando Ribeiro, Iván Cavero-Redondo","doi":"10.1136/jech-2025-224810","DOIUrl":"https://doi.org/10.1136/jech-2025-224810","url":null,"abstract":"<p><strong>Introduction: </strong>Accumulation of advanced glycation end products, measured by skin autofluorescence (SAF), has been shown to be associated with several chronic non-communicable diseases, particularly cardiovascular diseases (CVDs). The promotion of physical activity (PA) as a strategy for the prevention of CVD by modifying healthy habits has been widely studied.</p><p><strong>Aim: </strong>To assess the evidence for the association between PA and SAF in the general adult population.</p><p><strong>Methods: </strong>A systematic review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and the Synthesis Without Meta-analysis framework. A search was performed in MEDLINE (via PubMed), Web of Science, Scopus, Cochrane Library and SportDiscuss (via EBSCOhost), from inception to September 2024. Study quality was assessed using the National Heart, Lung and Blood Institute tools and the certainty of evidence was evaluated with Grading of Recommendations, Assessment Development and Evaluation. Vote counting based on the direction of effect was used as the standardised synthesis metric.</p><p><strong>Results: </strong>In the systematic review, 17 studies were included. The qualitative synthesis showed a predominant consistency in favour of a beneficial association. Specifically, 58.8% of the studies reported a statistically significant inverse association, indicating that higher levels of PA or exercise frequency are correlated with lower SAF levels. The remaining studies (41.2%) reported non-significant results, though several showed favourable trends. No studies reported a positive association between PA and SAF. The quality of the studies was generally fair, and the certainty of evidence low.</p><p><strong>Conclusions: </strong>PA is inversely associated with SAF. Therefore, while causality cannot be proven, it is hypothesised that PA may reduce SAF and thus have a positive impact on health.</p>","PeriodicalId":54839,"journal":{"name":"Journal of Epidemiology and Community Health","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147482289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-17DOI: 10.1136/jech-2025-224253
Elizabeth Wurtzler, Erica K Barnell, Catherine Morrison, Clayton Grass, Natalie DuPré, Donald J Biddle, Allie Jin, Sandy Kavalukas, Rochelle H Holm, Ted R Smith
Background: Individual screening for colorectal cancer (CRC) is typically performed through either direct clinical examination, such as a colonoscopy, or an approved non-invasive test that measures CRC markers shed from the tumour into stool. There are known barriers to current screening recommendations.
Methods: We present feasibility data demonstrating the detection of CRC-associated RNA biomarkers in community wastewater. RNA expression values for GAPDH (housekeeping marker) and CDH1 (colorectal neoplasia-associated marker) were quantified via droplet digital PCR. The CDH1 region evaluated in this study represents overall CDH1 concentration in wastewater samples, with elevated expression shown to be associated with colorectal neoplasia. Four neighbourhood clusters were assessed in this study: three CRC clusters (CRC Clusters #1-#3) and one control region (Control Cluster #1).
Results: Average normalised colorectal neoplasia-associated RNA markers (CDH1/GAPDH) for CRC clusters were 20.0 (CRC Cluster #1), 2.2 (CRC Cluster #2) and 4.0 (CRC Cluster #3); average normalised colorectal neoplasia-associated RNA markers (CDH1/GAPDH) for Control Cluster #1 were 2.6.
Conclusion: Our data provide proof of principle for a novel application of wastewater surveillance to track potential cancer burden. We demonstrate that CDH1 is detectable in wastewater, potentially accelerating the development of this approach for epidemiological studies. Further investigation with additional samples and closer alignment with documented case activity will be necessary in future population-level CRC surveillance research.
{"title":"Using wastewater for population-level colorectal cancer surveillance: a future research agenda.","authors":"Elizabeth Wurtzler, Erica K Barnell, Catherine Morrison, Clayton Grass, Natalie DuPré, Donald J Biddle, Allie Jin, Sandy Kavalukas, Rochelle H Holm, Ted R Smith","doi":"10.1136/jech-2025-224253","DOIUrl":"https://doi.org/10.1136/jech-2025-224253","url":null,"abstract":"<p><strong>Background: </strong>Individual screening for colorectal cancer (CRC) is typically performed through either direct clinical examination, such as a colonoscopy, or an approved non-invasive test that measures CRC markers shed from the tumour into stool. There are known barriers to current screening recommendations.</p><p><strong>Methods: </strong>We present feasibility data demonstrating the detection of CRC-associated RNA biomarkers in community wastewater. RNA expression values for GAPDH (housekeeping marker) and CDH1 (colorectal neoplasia-associated marker) were quantified via droplet digital PCR. The CDH1 region evaluated in this study represents overall CDH1 concentration in wastewater samples, with elevated expression shown to be associated with colorectal neoplasia. Four neighbourhood clusters were assessed in this study: three CRC clusters (CRC Clusters #1-#3) and one control region (Control Cluster #1).</p><p><strong>Results: </strong>Average normalised colorectal neoplasia-associated RNA markers (CDH1/GAPDH) for CRC clusters were 20.0 (CRC Cluster #1), 2.2 (CRC Cluster #2) and 4.0 (CRC Cluster #3); average normalised colorectal neoplasia-associated RNA markers (CDH1/GAPDH) for Control Cluster #1 were 2.6.</p><p><strong>Conclusion: </strong>Our data provide proof of principle for a novel application of wastewater surveillance to track potential cancer burden. We demonstrate that CDH1 is detectable in wastewater, potentially accelerating the development of this approach for epidemiological studies. Further investigation with additional samples and closer alignment with documented case activity will be necessary in future population-level CRC surveillance research.</p>","PeriodicalId":54839,"journal":{"name":"Journal of Epidemiology and Community Health","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147476523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Onychomycosis is a common fungal nail infection worldwide; however, comprehensive data on global prevalence, causative pathogens, risk factors and socioeconomic distribution remain limited. This study examines these aspects globally to inform clinical practice.
Methods: This systematic review, registered on PROSPERO and following Preferred Reporting Items for Systematic Reviews and Meta-analyses and Meta-analyses of Observational Studies in Epidemiology guidelines, searched Scopus, PubMed and EMBASE for English-language studies published from January 2013 to September 2023 reporting on onychomycosis prevalence. A random-effects model estimated global prevalence, with meta-regression and subgroup analyses by study setting, region, income level, demographics and fungal species.
Results: Of 4961 studies, 219 were included. The pooled prevalence among tested samples was 22.91% (95% CI 20.32% to 25.60%). Laboratory-based, medical centre-based or hospital-based studies showed higher prevalence (24.19%; 95% CI 20.99% to 27.54%) compared with community-based studies (8.57%; 95% CI 6.77% to 10.55%). Prevalence was highest in Southeast Asia (42.99%) and lowest in West Asia (16.15%). High-income countries exhibited a prevalence of 25.90%, compared with 17.76% in low-income countries. Prevalence was comparable for men (31.54%) and women (30.05%), peaking at ages 41-50 years (25.05%). Higher prevalence was observed among individuals with metabolic disorders (53.96%) and occlusive footwear users (44.17%). Dermatophytes predominated (53.03%), followed by non-dermatophyte moulds (22.30%) and yeasts (22.12%), with regional differences.
Conclusions: Onychomycosis represents a considerable global health burden that varies by study setting, geographic region and socioeconomic factors. Given the low to very low certainty of evidence primarily from healthcare settings, these findings underscore the need for more community-based epidemiological research and the importance of targeted prevention and effective management strategies.
Prospero registration number: CRD42024501728.
背景:甲真菌病是一种常见的指甲真菌感染;然而,关于全球流行率、致病病原体、风险因素和社会经济分布的综合数据仍然有限。本研究在全球范围内考察了这些方面,以告知临床实践。方法:本系统综述在PROSPERO上注册,并遵循流行病学指南中观察性研究的系统综述、荟萃分析和荟萃分析的首选报告项目,检索Scopus、PubMed和EMBASE,检索2013年1月至2023年9月发表的关于甲真菌病患病率的英语研究。随机效应模型估计了全球流行率,并根据研究环境、地区、收入水平、人口统计和真菌种类进行了meta回归和亚组分析。结果:4961项研究中,219项被纳入。检测样本的总患病率为22.91% (95% CI为20.32% ~ 25.60%)。以实验室为基础、以医疗中心为基础或以医院为基础的研究显示,与以社区为基础的研究(8.57%;95% CI 6.77%至10.55%)相比,患病率更高(24.19%;95% CI 20.99%至27.54%)。东南亚患病率最高(42.99%),西亚最低(16.15%)。高收入国家的患病率为25.90%,而低收入国家为17.76%。男性(31.54%)和女性(30.05%)的患病率相当,在41-50岁达到高峰(25.05%)。代谢性疾病患者(53.96%)和鞋履使用者(44.17%)的患病率较高。以皮生菌为主(53.03%),其次为非皮生菌霉菌(22.30%)和酵母菌(22.12%),存在区域差异。结论:甲真菌病是一种相当大的全球健康负担,因研究环境、地理区域和社会经济因素而异。鉴于主要来自卫生保健机构的证据的低到极低的确定性,这些发现强调需要进行更多以社区为基础的流行病学研究,以及有针对性的预防和有效管理策略的重要性。普洛斯彼罗注册号:CRD42024501728。
{"title":"Global and regional prevalence, aetiology and socioeconomic distribution of onychomycosis: a systematic review and meta-analysis (2013-2023).","authors":"Pakpoom Wongyikul, Lalita Lumkul, Kanya Preechasuth, Phichayut Phinyo, Panjit Chieosilapatham","doi":"10.1136/jech-2025-224978","DOIUrl":"https://doi.org/10.1136/jech-2025-224978","url":null,"abstract":"<p><strong>Background: </strong>Onychomycosis is a common fungal nail infection worldwide; however, comprehensive data on global prevalence, causative pathogens, risk factors and socioeconomic distribution remain limited. This study examines these aspects globally to inform clinical practice.</p><p><strong>Methods: </strong>This systematic review, registered on PROSPERO and following Preferred Reporting Items for Systematic Reviews and Meta-analyses and Meta-analyses of Observational Studies in Epidemiology guidelines, searched Scopus, PubMed and EMBASE for English-language studies published from January 2013 to September 2023 reporting on onychomycosis prevalence. A random-effects model estimated global prevalence, with meta-regression and subgroup analyses by study setting, region, income level, demographics and fungal species.</p><p><strong>Results: </strong>Of 4961 studies, 219 were included. The pooled prevalence among tested samples was 22.91% (95% CI 20.32% to 25.60%). Laboratory-based, medical centre-based or hospital-based studies showed higher prevalence (24.19%; 95% CI 20.99% to 27.54%) compared with community-based studies (8.57%; 95% CI 6.77% to 10.55%). Prevalence was highest in Southeast Asia (42.99%) and lowest in West Asia (16.15%). High-income countries exhibited a prevalence of 25.90%, compared with 17.76% in low-income countries. Prevalence was comparable for men (31.54%) and women (30.05%), peaking at ages 41-50 years (25.05%). Higher prevalence was observed among individuals with metabolic disorders (53.96%) and occlusive footwear users (44.17%). Dermatophytes predominated (53.03%), followed by non-dermatophyte moulds (22.30%) and yeasts (22.12%), with regional differences.</p><p><strong>Conclusions: </strong>Onychomycosis represents a considerable global health burden that varies by study setting, geographic region and socioeconomic factors. Given the low to very low certainty of evidence primarily from healthcare settings, these findings underscore the need for more community-based epidemiological research and the importance of targeted prevention and effective management strategies.</p><p><strong>Prospero registration number: </strong>CRD42024501728.</p>","PeriodicalId":54839,"journal":{"name":"Journal of Epidemiology and Community Health","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147445747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-12DOI: 10.1136/jech-2025-224885
Christopher Lübker, Sara Holloway, Edward Gregg, Jonathan Pearson-Stuttard
Background: To quantify inequalities in obesity-related complication (ORC) prevalence and differences in healthcare costs between the most (Q1) and least (Q5) deprived quintiles of people living with obesity.
Methods: Retrospective, open cohort study of ~2.5 million people residing in North-West London using linked primary and secondary electronic health records. Individuals aged ≥18 years living with obesity (body mass index ≥30 kg/m2) between 1 January 2016 and 31 December 2019 were eligible. The population was stratified into deprivation quintiles per the Index of Multiple Deprivation (IMD). Individuals were grouped into non-mutually exclusive ORC prevalence groups covering 27 ORCs, including ORC multimorbidity. Primary outcomes were ORC prevalence and healthcare cost differences between the lowest and the highest deprivation quintiles. ORC prevalence and healthcare costs were age-standardised to the European Standard Population.
Results: Out of 362 023 people living with obesity, 64 866 were in IMD Q1 (most deprived) and 24 590 in Q5. The largest ORC prevalence differences between Q1 and Q5 were seen in conditions with highest prevalence overall: type 2 diabetes (5.1 percentage point prevalence difference; 19.5% prevalence), hypertension (3.8, 32.7%) and depression (3.4, 6.3%). The percentage point prevalence difference was larger with increasing ORC multimorbidity: 1.2 for at least one, 3.7 for at least two and 4.0 for at least three ORCs. Healthcare costs were greater in the most deprived quintile compared with the least deprived quintile for every ORC population, with the largest differences seen in peripheral arterial disease (£2801 cost difference), cancer (£2785), renal failure (£2108).
Conclusions: Targeted interventions proportionate to these health and cost burdens could improve health equity and reduce healthcare cost, yet their causal drivers require further study.
{"title":"Inequality in obesity complications, multimorbidity and healthcare costs by deprivation group among people living with obesity: a UK observational study.","authors":"Christopher Lübker, Sara Holloway, Edward Gregg, Jonathan Pearson-Stuttard","doi":"10.1136/jech-2025-224885","DOIUrl":"https://doi.org/10.1136/jech-2025-224885","url":null,"abstract":"<p><strong>Background: </strong>To quantify inequalities in obesity-related complication (ORC) prevalence and differences in healthcare costs between the most (Q1) and least (Q5) deprived quintiles of people living with obesity.</p><p><strong>Methods: </strong>Retrospective, open cohort study of ~2.5 million people residing in North-West London using linked primary and secondary electronic health records. Individuals aged ≥18 years living with obesity (body mass index ≥30 kg/m<sup>2</sup>) between 1 January 2016 and 31 December 2019 were eligible. The population was stratified into deprivation quintiles per the Index of Multiple Deprivation (IMD). Individuals were grouped into non-mutually exclusive ORC prevalence groups covering 27 ORCs, including ORC multimorbidity. Primary outcomes were ORC prevalence and healthcare cost differences between the lowest and the highest deprivation quintiles. ORC prevalence and healthcare costs were age-standardised to the European Standard Population.</p><p><strong>Results: </strong>Out of 362 023 people living with obesity, 64 866 were in IMD Q1 (most deprived) and 24 590 in Q5. The largest ORC prevalence differences between Q1 and Q5 were seen in conditions with highest prevalence overall: type 2 diabetes (5.1 percentage point prevalence difference; 19.5% prevalence), hypertension (3.8, 32.7%) and depression (3.4, 6.3%). The percentage point prevalence difference was larger with increasing ORC multimorbidity: 1.2 for at least one, 3.7 for at least two and 4.0 for at least three ORCs. Healthcare costs were greater in the most deprived quintile compared with the least deprived quintile for every ORC population, with the largest differences seen in peripheral arterial disease (£2801 cost difference), cancer (£2785), renal failure (£2108).</p><p><strong>Conclusions: </strong>Targeted interventions proportionate to these health and cost burdens could improve health equity and reduce healthcare cost, yet their causal drivers require further study.</p>","PeriodicalId":54839,"journal":{"name":"Journal of Epidemiology and Community Health","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147445872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-12DOI: 10.1136/jech-2025-225231
Flora Le, Dorothea Dumuid, Olivia D'Elia, Alexander Haussmann, Emmanuel Stamatakis, Yue Liao, Aiden Doherty, Joshua F Wiley
Background: Behaviours across a 24-hour day, including physical activity, sedentary time and sleep, are disrupted following cancer and contribute to cancer-related outcomes. This study describes the day-to-day 24-hour behaviour profiles of individuals with and without cancer, considering time since diagnosis and cancer types.
Methods: Seven days of accelerometer data from the UK Biobank (M±SDage=62.3±7.9 years; 56.4% female) were derived from machine learning models to assess the 24-hour behaviours in individuals with cancer (n=10 152; M±SDyears since diagnosis=7.4±6.1 years) compared with healthy (free of diseases) individuals (n=13 722). Diagnoses were identified using the International Classification of Disease codes within cancer registries. Bayesian compositional data analysis compared profiles between individuals with and without cancer, across time since diagnosis (<1 year, 1-5 years, >5 years) and 14 cancer types.
Results: The least physically active profiles were observed for individuals within 1 year following cancer diagnosis and in cancers with poor prognoses. Compared with healthy individuals, those within 1 year following cancer diagnosis had 40 min/day less physical activity (light plus moderate-to-vigorous intensities), compensated by 40 min/day more inactive time (sedentary plus sleep periods). Differences also varied across cancer types, ranging from 22-75 min/day less physical activity and 22-75 min/day more inactive time, between individuals with cancers and healthy individuals. Cancers with poorer prognoses (eg, lung, gastrointestinal tract) had the least optimal profiles, whereas cancers with better prognoses (eg, prostate, skin) showed profiles closer to healthy individuals.
Conclusion: The 24-hour behaviour profiles differed by cancer history, prognosis and type. Supporting a healthy balance of behaviours, that can feasibly be achieved within a 24-hour day, should be considered for cancer survivors, particularly in the year after diagnosis and in poor prognosis cancers.
{"title":"24-hour physical activity, sedentary behaviour and sleep profiles in individuals with cancer: a UK Biobank cohort study.","authors":"Flora Le, Dorothea Dumuid, Olivia D'Elia, Alexander Haussmann, Emmanuel Stamatakis, Yue Liao, Aiden Doherty, Joshua F Wiley","doi":"10.1136/jech-2025-225231","DOIUrl":"https://doi.org/10.1136/jech-2025-225231","url":null,"abstract":"<p><strong>Background: </strong>Behaviours across a 24-hour day, including physical activity, sedentary time and sleep, are disrupted following cancer and contribute to cancer-related outcomes. This study describes the day-to-day 24-hour behaviour profiles of individuals with and without cancer, considering time since diagnosis and cancer types.</p><p><strong>Methods: </strong>Seven days of accelerometer data from the UK Biobank (M±SD<sub>age</sub>=62.3±7.9 years; 56.4% female) were derived from machine learning models to assess the 24-hour behaviours in individuals with cancer (n=10 152; M±SD<sub>years since diagnosis</sub>=7.4±6.1 years) compared with healthy (free of diseases) individuals (n=13 722). Diagnoses were identified using the International Classification of Disease codes within cancer registries. Bayesian compositional data analysis compared profiles between individuals with and without cancer, across time since diagnosis (<1 year, 1-5 years, >5 years) and 14 cancer types.</p><p><strong>Results: </strong>The least physically active profiles were observed for individuals within 1 year following cancer diagnosis and in cancers with poor prognoses. Compared with healthy individuals, those within 1 year following cancer diagnosis had 40 min/day less physical activity (light plus moderate-to-vigorous intensities), compensated by 40 min/day more inactive time (sedentary plus sleep periods). Differences also varied across cancer types, ranging from 22-75 min/day less physical activity and 22-75 min/day more inactive time, between individuals with cancers and healthy individuals. Cancers with poorer prognoses (eg, lung, gastrointestinal tract) had the least optimal profiles, whereas cancers with better prognoses (eg, prostate, skin) showed profiles closer to healthy individuals.</p><p><strong>Conclusion: </strong>The 24-hour behaviour profiles differed by cancer history, prognosis and type. Supporting a healthy balance of behaviours, that can feasibly be achieved within a 24-hour day, should be considered for cancer survivors, particularly in the year after diagnosis and in poor prognosis cancers.</p>","PeriodicalId":54839,"journal":{"name":"Journal of Epidemiology and Community Health","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147445086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-12DOI: 10.1136/jech-2025-225296
Beth Dorrans, Martha Tindall, Rachel M Thomson, Shona Mackinnon, Philip Broadbent, Valerie Wells, Andrea Elizabeth Williamson, Srinivasa Vittal Katikireddi
Background: Non-communicable diseases (NCDs) represent a significant cause of morbidity and mortality globally. Despite a strong evidence base outlining increased risk of communicable diseases and poor mental health in people who have experienced imprisonment, the risk of NCDs has not been quantified in previous reviews. This study aimed to describe the incidence of morbidity and mortality of physical NCDs in people who have experienced imprisonment compared with the general population in high-income countries.
Methods: We searched MEDLINE, Embase, CINAHL and SocINDEX (PROSPERO CRD42024540173) for comparative studies of morbidity or mortality from NCDs. Articles were assessed against predefined criteria to select studies that included people with experience of imprisonment; measured NCD incidence; compared incidence to a general population; and were conducted in a high-income country. Two reviewers conducted independent risk of bias assessment using an adapted version of the Newcastle-Ottawa Scale. Data were synthesised using random-effects meta-analyses and vote counting based on effect direction. Meta-regression and subgroup analysis investigated heterogeneity.
Results: Of 3085 articles screened, 32 were included providing 341 datapoints. Meta-analysis showed a higher risk of mortality from several diseases, including respiratory disease (risk ratio (RR) 2.38 (95% CI 1.18 to 4.80), I2=97%), cardiovascular disease (RR 1.80 (95% CI 1.32 to 2.46), I2=99%), liver disease and cirrhosis (RR 2.50 (95% CI 1.08 to 5.77), I2=99%), digestive disease (RR 2.92 (95% CI 1.09 to 7.78), I2=99%), neurological disease (RR 1.94 (95% CI 1.09 to 3.44), I2=92%), head and neck cancer (RR 21.31 (95% CI 4.32 to 105.14), I2=97%), liver cancer (RR 4.07 (95% CI 2.34 to 7.08), I2=94%), cervical cancer (RR 3.95 (95% CI 3.11 to 5.01), I2=0%) and lung cancer (RR 1.95 (95% CI 1.34 to 2.85), I2=0%). Synthesis without meta-analysis also indicated imprisonment was associated with increased morbidity from multiple NCDs.
Conclusions: Several NCDs, including multiple cancers, cardiovascular disease, respiratory disease and liver disease, are substantially more common in people who have experienced imprisonment compared with the general population, highlighting a need for primary prevention and NCD management.
背景:非传染性疾病(NCDs)是全球发病率和死亡率的重要原因。尽管有强有力的证据表明,经历过监禁的人患传染病的风险增加,精神健康状况不佳,但在以前的审查中,未对非传染性疾病的风险进行量化。本研究旨在描述与高收入国家的一般人群相比,经历过监禁的人的身体非传染性疾病的发病率和死亡率。方法:我们检索MEDLINE、Embase、CINAHL和SocINDEX (PROSPERO CRD42024540173),查找非传染性疾病发病率或死亡率的比较研究。根据预先确定的标准对文章进行评估,以选择包括有监禁经历的人的研究;测量的非传染性疾病发病率;与一般人群的发病率比较;并且是在高收入国家进行的。两名评论者使用纽卡斯尔-渥太华量表进行了独立的偏倚风险评估。使用随机效应荟萃分析和基于效应方向的计票来综合数据。meta回归和亚组分析研究异质性。结果:在筛选的3085篇文章中,32篇纳入,提供了341个数据点。meta分析显示,几种疾病的死亡率较高,包括呼吸系统疾病(风险比(RR) 2.38 (95% CI 1.18 ~ 4.80), I2=97%)、心血管疾病(RR 1.80 (95% CI 1.32 ~ 2.46), I2=99%)、肝脏疾病和肝硬化(RR 2.50 (95% CI 1.08 ~ 5.77), I2=99%)、消化系统疾病(RR 2.92 (95% CI 1.09 ~ 7.78), I2=99%)、神经系统疾病(RR 1.94 (95% CI 1.09 ~ 3.44), I2=92%)、头颈癌(RR 21.31 (95% CI 4.32 ~ 105.14), I2=97%)。肝癌(RR 4.07 (95% CI 2.34 ~ 7.08), I2=94%),宫颈癌(RR 3.95 (95% CI 3.11 ~ 5.01), I2=0%),肺癌(RR 1.95 (95% CI 1.34 ~ 2.85), I2=0%)。未经荟萃分析的综合研究还表明,监禁与多种非传染性疾病的发病率增加有关。结论:几种非传染性疾病,包括多种癌症、心血管疾病、呼吸系统疾病和肝脏疾病,在经历过监禁的人群中比在一般人群中更为常见,突出表明需要进行初级预防和非传染性疾病管理。
{"title":"Incidence of physical non-communicable disease in people who have experienced imprisonment compared with the general population in high-income countries: a systematic review and meta-analysis.","authors":"Beth Dorrans, Martha Tindall, Rachel M Thomson, Shona Mackinnon, Philip Broadbent, Valerie Wells, Andrea Elizabeth Williamson, Srinivasa Vittal Katikireddi","doi":"10.1136/jech-2025-225296","DOIUrl":"https://doi.org/10.1136/jech-2025-225296","url":null,"abstract":"<p><strong>Background: </strong>Non-communicable diseases (NCDs) represent a significant cause of morbidity and mortality globally. Despite a strong evidence base outlining increased risk of communicable diseases and poor mental health in people who have experienced imprisonment, the risk of NCDs has not been quantified in previous reviews. This study aimed to describe the incidence of morbidity and mortality of physical NCDs in people who have experienced imprisonment compared with the general population in high-income countries.</p><p><strong>Methods: </strong>We searched MEDLINE, Embase, CINAHL and SocINDEX (PROSPERO CRD42024540173) for comparative studies of morbidity or mortality from NCDs. Articles were assessed against predefined criteria to select studies that included people with experience of imprisonment; measured NCD incidence; compared incidence to a general population; and were conducted in a high-income country. Two reviewers conducted independent risk of bias assessment using an adapted version of the Newcastle-Ottawa Scale. Data were synthesised using random-effects meta-analyses and vote counting based on effect direction. Meta-regression and subgroup analysis investigated heterogeneity.</p><p><strong>Results: </strong>Of 3085 articles screened, 32 were included providing 341 datapoints. Meta-analysis showed a higher risk of mortality from several diseases, including respiratory disease (risk ratio (RR) 2.38 (95% CI 1.18 to 4.80), I<sup>2</sup>=97%), cardiovascular disease (RR 1.80 (95% CI 1.32 to 2.46), I<sup>2</sup>=99%), liver disease and cirrhosis (RR 2.50 (95% CI 1.08 to 5.77), I<sup>2</sup>=99%), digestive disease (RR 2.92 (95% CI 1.09 to 7.78), I<sup>2</sup>=99%), neurological disease (RR 1.94 (95% CI 1.09 to 3.44), I<sup>2</sup>=92%), head and neck cancer (RR 21.31 (95% CI 4.32 to 105.14), I<sup>2</sup>=97%), liver cancer (RR 4.07 (95% CI 2.34 to 7.08), I<sup>2</sup>=94%), cervical cancer (RR 3.95 (95% CI 3.11 to 5.01), I<sup>2</sup>=0%) and lung cancer (RR 1.95 (95% CI 1.34 to 2.85), I<sup>2</sup>=0%). Synthesis without meta-analysis also indicated imprisonment was associated with increased morbidity from multiple NCDs.</p><p><strong>Conclusions: </strong>Several NCDs, including multiple cancers, cardiovascular disease, respiratory disease and liver disease, are substantially more common in people who have experienced imprisonment compared with the general population, highlighting a need for primary prevention and NCD management.</p>","PeriodicalId":54839,"journal":{"name":"Journal of Epidemiology and Community Health","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147445895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-10DOI: 10.1136/jech-2026-226120
Moritz Oberndorfer, Annie Herbert, S Vittal Katikireddi, Anna Pearce
{"title":"Descriptive estimands, causal estimands, and avoiding the jungle of adjusted associations 'in between'.","authors":"Moritz Oberndorfer, Annie Herbert, S Vittal Katikireddi, Anna Pearce","doi":"10.1136/jech-2026-226120","DOIUrl":"10.1136/jech-2026-226120","url":null,"abstract":"","PeriodicalId":54839,"journal":{"name":"Journal of Epidemiology and Community Health","volume":" ","pages":"205-206"},"PeriodicalIF":3.7,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147311932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-10DOI: 10.1136/jech-2025-224952
Mhairi Campbell, Bryony Dawkins, Gillian Fergie, Anne-Sophie Jung, Ruth Lewis, Lisa McDaid, Jonathan R Olsen, Roxana Pollack, Benjamin P Rigby, Mark Robinson, Kathryn Skivington, Michael Thomson, Anna Pearce
Addressing health inequalities is an international priority. Various approaches have gained popularity in the academic literature and policy-making documents. However, there has been a lack of progress in tackling health inequalities. We outline the main characteristics and principles of five commonly cited approaches: asset-based, place-based, upstream, systems-based and proportionate universalism. We examine how these approaches are described in the literature and the logic by which they are thought to tackle health inequalities.There was variation in how each approach was described and interpreted. The logic behind how the approaches could improve population health was clearly articulated but often under-developed with respect to health inequalities. Although rarely acknowledged explicitly, it was implied that these approaches seek to reduce health inequalities through focussing on more socially disadvantaged sub-groups in a population, identifying the most impactful intervention levers and/or working to minimise stigma and minimise inequalities in access and uptake of interventions. More attention should be paid to the important principles, features and underlying logic of these approaches in relation to health inequalities to better understand the potential supports and barriers to their success. This will support those working to implement them to do so in ways that are sensitive to local and contextual specificities.
{"title":"Commonly cited approaches to reducing health inequalities: a call for more clarity around their definition and underlying assumptions.","authors":"Mhairi Campbell, Bryony Dawkins, Gillian Fergie, Anne-Sophie Jung, Ruth Lewis, Lisa McDaid, Jonathan R Olsen, Roxana Pollack, Benjamin P Rigby, Mark Robinson, Kathryn Skivington, Michael Thomson, Anna Pearce","doi":"10.1136/jech-2025-224952","DOIUrl":"10.1136/jech-2025-224952","url":null,"abstract":"<p><p>Addressing health inequalities is an international priority. Various approaches have gained popularity in the academic literature and policy-making documents. However, there has been a lack of progress in tackling health inequalities. We outline the main characteristics and principles of five commonly cited approaches: asset-based, place-based, upstream, systems-based and proportionate universalism. We examine how these approaches are described in the literature and the logic by which they are thought to tackle health inequalities.There was variation in how each approach was described and interpreted. The logic behind how the approaches could improve population health was clearly articulated but often under-developed with respect to health inequalities. Although rarely acknowledged explicitly, it was implied that these approaches seek to reduce health inequalities through focussing on more socially disadvantaged sub-groups in a population, identifying the most impactful intervention levers and/or working to minimise stigma and minimise inequalities in access and uptake of interventions. More attention should be paid to the important principles, features and underlying logic of these approaches in relation to health inequalities to better understand the potential supports and barriers to their success. This will support those working to implement them to do so in ways that are sensitive to local and contextual specificities.</p>","PeriodicalId":54839,"journal":{"name":"Journal of Epidemiology and Community Health","volume":" ","pages":"259-265"},"PeriodicalIF":3.7,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145716937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-10DOI: 10.1136/jech-2025-224637
Luke T Bayliss, Alison Kelly, Sadhvi Krishnamoorthy, Michael Lam, Linda Hassall, Kairi Kolves
Background: Theatre interventions such as psychodrama are increasingly being used to help individuals with mental health conditions. Previous findings provided mixed results on the impact of theatre interventions for reducing psychological symptoms. Given the growing use of theatre interventions, it is important to investigate their impact on specific mental health conditions. This systematic review and meta-analysis aims to examine the impact of theatre interventions on mental health outcomes and suicidality.
Methods: The review was prospectively registered on The International Prospective Register of Systematic Reviews (CRD42021212666), and followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines for reporting. Embase, ProQuest Central, PsycInfo, PubMed and Scopus were searched. All English-language studies examining the impact of theatre interventions and on mental health outcomes and/or suicidality were included.
Results: In total, 42 papers met the inclusion criteria. Of these, 21 studies were included in meta-analyses that found significant reductions in standardised mean change using raw score standardisation symptoms of anxiety (k=10; -0.45 (95% CI -0.71 to -0.19)) depression (k=16; -0.79 (95% CI -1.07 to -0.51)) and post-traumatic stress disorder (k=6; -0.82 (95% CI -1.21 to -0.42)) among adult participants of theatre intervention studies. Results from studies excluded from meta-analyses indicated that theatre interventions helped reduce symptoms of schizophrenia and psychosis for adults and lowered the risk of suicidal ideation and suicide attempt among adolescents. Most studies had a high/serious risk or some concerns about bias.
Conclusion: Theatre interventions may be useful to help reduce symptoms of mental health conditions. Further high-quality research is necessary to build on the existing evidence and to assess both the short- and long-term impacts of theatre interventions on mental health outcomes.
背景:戏剧干预,如心理剧,越来越多地被用于帮助有心理健康状况的个人。先前的研究结果对剧场干预对减少心理症状的影响提供了不同的结果。鉴于戏剧干预的使用越来越多,调查它们对特定心理健康状况的影响是很重要的。本系统综述和荟萃分析旨在研究戏剧干预对心理健康结果和自杀行为的影响。方法:该综述在国际前瞻性系统评价登记册(CRD42021212666)上前瞻性注册,并遵循系统评价的首选报告项目和荟萃分析指南进行报告。检索Embase、ProQuest Central、PsycInfo、PubMed和Scopus。所有考察戏剧干预以及对心理健康结果和/或自杀行为影响的英语研究都被纳入其中。结果:共有42篇论文符合纳入标准。其中,21项研究被纳入荟萃分析,发现在戏剧干预研究的成人参与者中,使用原始评分标准化症状的标准化平均变化显著降低:焦虑(k=10; -0.45 (95% CI -0.71至-0.19))、抑郁(k=16; -0.79 (95% CI -1.07至-0.51))和创伤后应激障碍(k=6; -0.82 (95% CI -1.21至-0.42))。从荟萃分析中排除的研究结果表明,戏剧干预有助于减轻成人精神分裂症和精神病的症状,并降低青少年自杀意念和自杀企图的风险。大多数研究都有高/严重的风险或对偏倚的一些担忧。结论:剧场干预可能有助于减轻心理健康状况的症状。有必要进一步开展高质量的研究,以现有证据为基础,并评估戏剧干预对心理健康结果的短期和长期影响。
{"title":"Impact of theatre interventions on mental health: a systematic literature review and meta-analysis.","authors":"Luke T Bayliss, Alison Kelly, Sadhvi Krishnamoorthy, Michael Lam, Linda Hassall, Kairi Kolves","doi":"10.1136/jech-2025-224637","DOIUrl":"10.1136/jech-2025-224637","url":null,"abstract":"<p><strong>Background: </strong>Theatre interventions such as psychodrama are increasingly being used to help individuals with mental health conditions. Previous findings provided mixed results on the impact of theatre interventions for reducing psychological symptoms. Given the growing use of theatre interventions, it is important to investigate their impact on specific mental health conditions. This systematic review and meta-analysis aims to examine the impact of theatre interventions on mental health outcomes and suicidality.</p><p><strong>Methods: </strong>The review was prospectively registered on The International Prospective Register of Systematic Reviews (CRD42021212666), and followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines for reporting. Embase, ProQuest Central, PsycInfo, PubMed and Scopus were searched. All English-language studies examining the impact of theatre interventions and on mental health outcomes and/or suicidality were included.</p><p><strong>Results: </strong>In total, 42 papers met the inclusion criteria. Of these, 21 studies were included in meta-analyses that found significant reductions in standardised mean change using raw score standardisation symptoms of anxiety (k=10; -0.45 (95% CI -0.71 to -0.19)) depression (k=16; -0.79 (95% CI -1.07 to -0.51)) and post-traumatic stress disorder (k=6; -0.82 (95% CI -1.21 to -0.42)) among adult participants of theatre intervention studies. Results from studies excluded from meta-analyses indicated that theatre interventions helped reduce symptoms of schizophrenia and psychosis for adults and lowered the risk of suicidal ideation and suicide attempt among adolescents. Most studies had a high/serious risk or some concerns about bias.</p><p><strong>Conclusion: </strong>Theatre interventions may be useful to help reduce symptoms of mental health conditions. Further high-quality research is necessary to build on the existing evidence and to assess both the short- and long-term impacts of theatre interventions on mental health outcomes.</p>","PeriodicalId":54839,"journal":{"name":"Journal of Epidemiology and Community Health","volume":" ","pages":"251-258"},"PeriodicalIF":3.7,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145650085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}